Lyra Therapeutics
LYRA
LYRA
37 hedge funds and large institutions have $96M invested in Lyra Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$66K
Puts
–
Top Buyers
| 1 | +$576K | |
| 2 | +$186K | |
| 3 | +$132K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$108K |
| 5 |
Bank of New York Mellon
New York
|
+$98K |
Top Sellers
| 1 | -$620K | |
| 2 | -$351K | |
| 3 | -$344K | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$330K |
| 5 |
Two Sigma Investments
New York
|
-$76K |